Search Database

Select Protein (1 found)

UniProt ID Gene Symbol Protein Name Organism Length Action
H3BR35 GSPT1 G1 to S phase transition … Homo sapiens (Human) 475 aa

Protein Details: H3BR35 (GSPT1)

Protein Information
Accession H3BR35
Protein Names G1 to S phase transition 1
Gene Symbol GSPT1
Organism Homo sapiens (Human)
Length 475 aa
Isoforms No isoforms
Related PMIDs 31251020
Database Sources CysModDB dbPTM SwissPalm
These studies detected palmitoylation of this protein in the samples.
Tissue/Cell Line Expression
Tissue Specificity Index (TSI): 1.000
Bubble Size: Positive Samples Count Color Intensity: Positive Ratio
7
LNCaP cells
Specificity: 1.000
7/46 (15.2%)
0
Jurkat T cells
Specificity: 0.000
0/25 (0.0%)
0
U937 cells
Specificity: 0.000
0/1 (0.0%)
0
DU145 cells
Specificity: 0.000
0/2 (0.0%)
0
HeLa cells
Specificity: 0.000
0/1 (0.0%)
0
PC3 cells
Specificity: 0.000
0/4 (0.0%)
0
T cells
Specificity: 0.000
0/4 (0.0%)
0
HAP1 cells
Specificity: 0.000
0/10 (0.0%)
0
293T cells
Specificity: 0.000
0/10 (0.0%)
0
CEMx174 cells
Specificity: 0.000
0/3 (0.0%)
0
Endothelial cells
Specificity: 0.000
0/2 (0.0%)
0
Prefrontal cortex
Specificity: 0.000
0/1 (0.0%)
0
Cerebral cortex
Specificity: 0.000
0/4 (0.0%)
0
Liver membrane
Specificity: 0.000
0/1 (0.0%)
Palmitoylation Distribution by Study and Tissue/Cell Line
Chart Explanation: Each bar represents a study (PMID). The colored bottom segment shows palmitoylated samples, while the gray top segment shows non-palmitoylated samples. Bars are grouped by tissue/cell line for easy comparison.
Protein Sequence
Single Types:
Experimental Database High Prediction Medium Prediction Low Prediction
Combined Types:
All Three Exp + DB Exp + High Pred Exp + Med Pred Exp + Low Pred DB + High Pred DB + Med Pred DB + Low Pred Cysteine
1-501XSNSAVSMEL11SEPIENGETE21MSPEESWEHK31EEISEAEPGG41GSLGDGRPPE
51-10051ESAHEMMEEE61EEIPKPKSVV71APPGAPKKEH81VNVVFIGHVD91AGKSTIGGQI
101-150101MYLTGMVDKR111TLEKYEREAK121EKNRETWYLS131WALDTNQEER141DKGKTVEVGR
151-200151AYFETEKKHF161TILDAPGHKS171FVPNMIGGAS181QADLAVLVIS191ARKGEFETGF
201-250201EKGGQTREHA211MLAKTAGVKH221LIVLINKMDD231PTVNWSNERY241EECKEKLVPF
251-300251LKKVGFNPKK261DIHFMPCSGL271TGANLKEQSD281FCPWYIGLPF291IPYLDNLPNF
301-350301NRSVDGPIRL311PIVDKYKDMG321TVVLGKLESG331SICKGQQLVM341MPNKHNVEVL
351-400351GILSDDVETD361TVAPGENLKI371RLKGIEEEEI381LPGFILCDPN391NLCHSGRTFD
401-450401AQALICLVDK411KSGEKSKTRP421RFVKQDQVCI431ARLRTAGTIC441LETFKDFPQM
451-475451GRFTLRDEGK461TIAIGKVLKL471VPEKD
Palmitoylation Sites Details
Position Sources Domains Experimental PMIDs
267 Prediction (Medium) - -
333 Prediction (Medium) - -
387 CYSMODDB SWISSPALM DBPTM - -
393 CYSMODDB SWISSPALM DBPTM - -
406 Prediction (High) - -
429 Prediction (High) - -
440 Prediction (High) - -
TCGA Cysteine Mutation Information

Note: Mutations indicate amino acid changes that may create potential palmitoylation sites.

Position Amino Acid Change Frequency Type Function Cancer Type
410 Y → C 0.002545 SNP Missense Mutation GBM
456 R → C 0.001969 SNP Missense Mutation HNSC